Amedeo Smart

Free Medical Literature Service



Stem Cell Research

  Free Subscription

Articles published in
    September 2021
  1. FENG Q, Li S, Ma HM, Yang WT, et al
    LGR6 activates the Wnt/beta-catenin signaling pathway and forms a beta-catenin/TCF7L2/LGR6 feedback loop in LGR6(high) cervical cancer stem cells.
    Oncogene. 2021 Sep 6. pii: 10.1038/s41388-021-02002.
    >> Share

    August 2021
  2. ZHANG F, Li P, Liu S, Yang M, et al
    beta-Catenin-CCL2 feedback loop mediates crosstalk between cancer cells and macrophages that regulates breast cancer stem cells.
    Oncogene. 2021 Aug 3. pii: 10.1038/s41388-021-01986.
    >> Share

  3. YUAN S, Zhang P, Wen L, Jia S, et al
    miR-22 promotes stem cell traits via activating Wnt/beta-catenin signaling in cutaneous squamous cell carcinoma.
    Oncogene. 2021 Aug 3. pii: 10.1038/s41388-021-01973.
    >> Share

    June 2021
  4. VANOLI F, Meskauskaite B, Herviou L, Mallen W, et al
    Generation of human embryonic stem cell models to exploit the EWSR1-CREB fusion promiscuity as a common pathway of transformation in human tumors.
    Oncogene. 2021 Jun 30. pii: 10.1038/s41388-021-01843.
    >> Share

  5. CHEN T, Zhang F, Liu J, Huang Z, et al
    Dual role of WNT5A in promoting endothelial differentiation of glioma stem cells and angiogenesis of glioma derived endothelial cells.
    Oncogene. 2021 Jun 29. pii: 10.1038/s41388-021-01922.
    >> Share

  6. HAGIWARA M, Fushimi A, Yamashita N, Bhattacharya A, et al
    MUC1-C activates the PBAF chromatin remodeling complex in integrating redox balance with progression of human prostate cancer stem cells.
    Oncogene. 2021 Jun 23. pii: 10.1038/s41388-021-01899.
    >> Share

  7. MCANDREWS KM, Vazquez-Arreguin K, Kwak C, Sugimoto H, et al
    alphaSMA(+) fibroblasts suppress Lgr5(+) cancer stem cells and restrain colorectal cancer progression.
    Oncogene. 2021 Jun 9. pii: 10.1038/s41388-021-01866.
    >> Share

    April 2021
  8. ZHOU M, Zhang X, Liu C, Nie D, et al
    Targeting protein lysine methyltransferase G9A impairs self-renewal of chronic myelogenous leukemia stem cells via upregulation of SOX6.
    Oncogene. 2021 Apr 30. pii: 10.1038/s41388-021-01799.
    >> Share

    March 2021
  9. WANG YH, Chan YT, Hung TH, Hung JT, et al
    Transmembrane and coiled-coil domain family 3 (TMCC3) regulates breast cancer stem cell and AKT activation.
    Oncogene. 2021 Mar 19. pii: 10.1038/s41388-021-01729.
    >> Share

  10. FUKASAWA K, Kadota T, Horie T, Tokumura K, et al
    CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathway.
    Oncogene. 2021 Mar 16. pii: 10.1038/s41388-021-01745.
    >> Share

  11. KERR C, Szmacinski H, Fisher ML, Nance B, et al
    Correction to: Transamidase site-targeted agents alter the conformation of the transglutaminase cancer stem cell survival protein to reduce GTP binding activity and cancer stem cell survival.
    Oncogene. 2021 Mar 3. pii: 10.1038/s41388-021-01709.
    >> Share

  12. SIRKISOON SR, Carpenter RL, Rimkus T, Doheny D, et al
    Correction: TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment.
    Oncogene. 2021 Mar 2. pii: 10.1038/s41388-020-01620.
    >> Share

  13. WANG M, Zhao X, Qiu R, Gong Z, et al
    Lymph node metastasis-derived gastric cancer cells educate bone marrow-derived mesenchymal stem cells via YAP signaling activation by exosomal Wnt5a.
    Oncogene. 2021 Mar 2. pii: 10.1038/s41388-021-01722.
    >> Share

  14. BIE Q, Song H, Chen X, Yang X, et al
    IL-17B/IL-17RB signaling cascade contributes to self-renewal and tumorigenesis of cancer stem cells by regulating Beclin-1 ubiquitination.
    Oncogene. 2021 Mar 1. pii: 10.1038/s41388-021-01699.
    >> Share

    February 2021
  15. KIM JY, Kim HJ, Jung CW, Choi BI, et al
    Correction: PARK7 maintains the stemness of glioblastoma stem cells by stabilizing epidermal growth factor receptor variant III.
    Oncogene. 2021 Feb 8. pii: 10.1038/s41388-021-01644.
    >> Share

  16. LU J, Bang H, Kim SM, Cho SJ, et al
    Lymphatic metastasis-related TBL1XR1 enhances stemness and metastasis in gastric cancer stem-like cells by activating ERK1/2-SOX2 signaling.
    Oncogene. 2021;40:922-936.
    >> Share

    January 2021
  17. ZHU P, He F, Hou Y, Tu G, et al
    A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability.
    Oncogene. 2021 Jan 19. pii: 10.1038/s41388-020-01638.
    >> Share

  18. BAI J, Yokomizo-Nakano T, Kubota S, Sun Y, et al
    Overexpression of Hmga2 activates Igf2bp2 and remodels transcriptional program of Tet2-deficient stem cells in myeloid transformation.
    Oncogene. 2021 Jan 15. pii: 10.1038/s41388-020-01629.
    >> Share

  19. KIM HJ, Kim JY, Jung CW, Lee YS, et al
    ANO1 regulates the maintenance of stemness in glioblastoma stem cells by stabilizing EGFRvIII.
    Oncogene. 2021 Jan 15. pii: 10.1038/s41388-020-01612.
    >> Share

  20. KAUSHIK G, Seshacharyulu P, Rauth S, Nallasamy P, et al
    Selective inhibition of stemness through EGFR/FOXA2/SOX9 axis reduces pancreatic cancer metastasis.
    Oncogene. 2021;40:848-862.
    >> Share

  21. LIN WH, Chang YW, Hong MX, Hsu TC, et al
    STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT-MET switch and cancer metastasis.
    Oncogene. 2021;40:791-805.
    >> Share

    December 2020
  22. BERGIN CJ, Zouggar A, Haebe JR, Masibag AN, et al
    G9a controls pluripotent-like identity and tumor-initiating function in human colorectal cancer.
    Oncogene. 2020 Dec 15. pii: 10.1038/s41388-020-01591.
    >> Share

  23. HAN J, Qu H, Han M, Ding Y, et al
    MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer.
    Oncogene. 2020 Dec 3. pii: 10.1038/s41388-020-01574.
    >> Share

    November 2020
  24. SARI IN, Yang YG, Wijaya YT, Jun N, et al
    AMD1 is required for the maintenance of leukemic stem cells and promotes chronic myeloid leukemic growth.
    Oncogene. 2020 Nov 17. pii: 10.1038/s41388-020-01547.
    >> Share

  25. KIM JY, Kim HJ, Jung CW, Choi BI, et al
    PARK7 maintains the stemness of glioblastoma stem cells by stabilizing epidermal growth factor receptor variant III.
    Oncogene. 2020 Nov 13. pii: 10.1038/s41388-020-01543.
    >> Share

    October 2020
  26. JIA Y, Ding X, Zhou L, Zhang L, et al
    Mesenchymal stem cells-derived exosomal microRNA-139-5p restrains tumorigenesis in bladder cancer by targeting PRC1.
    Oncogene. 2020 Oct 29. pii: 10.1038/s41388-020-01486.
    >> Share

  27. YOSHIDA A, Choi J, Jin HR, Li Y, et al
    Fbxl8 suppresses lymphoma growth and hematopoietic transformation through degradation of cyclin D3.
    Oncogene. 2020 Oct 29. pii: 10.1038/s41388-020-01532.
    >> Share

  28. NIMMAKAYALA RK, Leon F, Rachagani S, Rauth S, et al
    Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.
    Oncogene. 2020 Oct 27. pii: 10.1038/s41388-020-01518.
    >> Share

  29. ANGEL I, Pilo Kerman O, Rousso-Noori L, Friedmann-Morvinski D, et al
    Tenascin C promotes cancer cell plasticity in mesenchymal glioblastoma.
    Oncogene. 2020 Oct 19. pii: 10.1038/s41388-020-01506.
    >> Share

  30. UKAI S, Honma R, Sakamoto N, Yamamoto Y, et al
    Molecular biological analysis of 5-FU-resistant gastric cancer organoids; KHDRBS3 contributes to the attainment of features of cancer stem cell.
    Oncogene. 2020 Oct 12. pii: 10.1038/s41388-020-01492.
    >> Share

  31. LATTIER JM, De A, Chen Z, Morales JE, et al
    Megalencephalic leukoencephalopathy with subcortical cysts 1 (MLC1) promotes glioblastoma cell invasion in the brain microenvironment.
    Oncogene. 2020 Oct 10. pii: 10.1038/s41388-020-01503.
    >> Share

  32. CHU Y, Chen Y, Guo H, Li M, et al
    SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia.
    Oncogene. 2020 Oct 9. pii: 10.1038/s41388-020-01495.
    >> Share

  33. CHEN Y, Xu L, Lin RY, Muschen M, et al
    Core transcriptional regulatory circuitries in cancer.
    Oncogene. 2020;39:6633-6646.
    >> Share

    September 2020
  34. KARRA L, Romero-Moya D, Ksionda O, Krush M, et al
    Increased baseline RASGRP1 signals enhance stem cell fitness during native hematopoiesis.
    Oncogene. 2020 Sep 28. pii: 10.1038/s41388-020-01469.
    >> Share

  35. GAN T, Stevens AT, Xiong X, Wen YA, et al
    Inhibition of protein tyrosine phosphatase receptor type F suppresses Wnt signaling in colorectal cancer.
    Oncogene. 2020 Sep 24. pii: 10.1038/s41388-020-01472.
    >> Share

  36. DOHENY D, Sirkisoon S, Carpenter RL, Aguayo NR, et al
    Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis.
    Oncogene. 2020 Sep 14. pii: 10.1038/s41388-020-01454.
    >> Share

    August 2020
  37. CHI HC, Tsai CY, Wang CS, Yang HY, et al
    DOCK6 promotes chemo- and radioresistance of gastric cancer by modulating WNT/beta-catenin signaling and cancer stem cell traits.
    Oncogene. 2020 Aug 4. pii: 10.1038/s41388-020-01390.
    >> Share

    July 2020
  38. BUSCHHAUS JM, Humphries BA, Eckley SS, Robison TH, et al
    Targeting disseminated estrogen-receptor-positive breast cancer cells in bone marrow.
    Oncogene. 2020 Jul 16. pii: 10.1038/s41388-020-01391.
    >> Share

  39. TODA J, Ichii M, Oritani K, Shibayama H, et al
    Signal-transducing adapter protein-1 is required for maintenance of leukemic stem cells in CML.
    Oncogene. 2020 Jul 13. pii: 10.1038/s41388-020-01387.
    >> Share

  40. JAMAL SME, Alamodi A, Wahl RU, Grada Z, et al
    Melanoma stem cell maintenance and chemo-resistance are mediated by CD133 signal to PI3K-dependent pathways.
    Oncogene. 2020 Jul 2. pii: 10.1038/s41388-020-1373.
    >> Share

  41. CHAI TF, Manu KA, Casey PJ, Wang M, et al
    Isoprenylcysteine carboxylmethyltransferase is required for the impact of mutant KRAS on TAZ protein level and cancer cell self-renewal.
    Oncogene. 2020;39:5373-5389.
    >> Share

    June 2020
  42. LIN CC, Yao CY, Hsu YC, Hou HA, et al
    Knock-out of Hopx disrupts stemness and quiescence of hematopoietic stem cells in mice.
    Oncogene. 2020 Jun 12. pii: 10.1038/s41388-020-1340.
    >> Share

  43. PORTNEY BA, Arad M, Gupta A, Brown RA, et al
    ZSCAN4 facilitates chromatin remodeling and promotes the cancer stem cell phenotype.
    Oncogene. 2020 Jun 7. pii: 10.1038/s41388-020-1333.
    >> Share

    May 2020
  44. SIMOES BM, Santiago-Gomez A, Chiodo C, Moreira T, et al
    Targeting STAT3 signaling using stabilised sulforaphane (SFX-01) inhibits endocrine resistant stem-like cells in ER-positive breast cancer.
    Oncogene. 2020 May 30. pii: 10.1038/s41388-020-1335.
    >> Share

  45. OKUMURA K, Saito M, Yoshizawa Y, Ito Y, et al
    Pak1 maintains epidermal stem cells by regulating Langerhans cells and is required for skin carcinogenesis.
    Oncogene. 2020 May 19. pii: 10.1038/s41388-020-1323.
    >> Share

  46. ZHANG C, Huang S, Zhuang H, Ruan S, et al
    YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.
    Oncogene. 2020 May 4. pii: 10.1038/s41388-020-1303.
    >> Share

  47. SIMON T, Jackson E, Giamas G
    Breaking through the glioblastoma micro-environment via extracellular vesicles.
    Oncogene. 2020 May 4. pii: 10.1038/s41388-020-1308.
    >> Share

  48. CAVE DD, Di Guida M, Costa V, Sevillano M, et al
    TGF-beta1 secreted by pancreatic stellate cells promotes stemness and tumourigenicity in pancreatic cancer cells through L1CAM downregulation.
    Oncogene. 2020;39:4271-4285.
    >> Share

  49. LARTIGUE L, Merle C, Lagarde P, Delespaul L, et al
    Genome remodeling upon mesenchymal tumor cell fusion contributes to tumor progression and metastatic spread.
    Oncogene. 2020;39:4198-4211.
    >> Share

    The premise of personalized immunotherapy for cancer dormancy.
    Oncogene. 2020;39:4323-4330.
    >> Share

    April 2020
  51. YIN H, Jiang Z, Feng X, Ji Z, et al
    Identification of Sca-1(+)Abcg1(+) bronchioalveolar epithelial cells as the origin of lung adenocarcinoma in Gprc5a-knockout mouse model through the interaction between lung progenitor AT2 and Lgr5 cells.
    Oncogene. 2020;39:3754-3773.
    >> Share

  52. REDONDO MONTE E, Wilding A, Leubolt G, Kerbs P, et al
    ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cells.
    Oncogene. 2020;39:3195-3205.
    >> Share

    February 2020
  53. YOE J, Kim D, Kim S, Lee Y, et al
    Capicua restricts cancer stem cell-like properties in breast cancer cells.
    Oncogene. 2020 Feb 27. pii: 10.1038/s41388-020-1230.
    >> Share

    January 2020
  54. RICCI B, Millner TO, Pomella N, Zhang X, et al
    Polycomb-mediated repression of EphrinA5 promotes growth and invasion of glioblastoma.
    Oncogene. 2020 Jan 27. pii: 10.1038/s41388-020-1161.
    >> Share

  55. MCGINN O, Ward AV, Fettig LM, Riley D, et al
    Cytokeratin 5 alters beta-catenin dynamics in breast cancer cells.
    Oncogene. 2020 Jan 27. pii: 10.1038/s41388-020-1164.
    >> Share

  56. CHEN CJ, Yang CJ, Yang SF, Huang MS, et al
    The MyoD family inhibitor domain-containing protein enhances the chemoresistance of cancer stem cells in the epithelial state by increasing beta-catenin activity.
    Oncogene. 2020 Jan 7. pii: 10.1038/s41388-019-1152.
    >> Share

  57. SCHAEFER T, Lengerke C
    SOX2 protein biochemistry in stemness, reprogramming, and cancer: the PI3K/AKT/SOX2 axis and beyond.
    Oncogene. 2020;39:278-292.
    >> Share

  58. WANG L, Zhao H, Li J, Xu Y, et al
    Identifying functions and prognostic biomarkers of network motifs marked by diverse chromatin states in human cell lines.
    Oncogene. 2020;39:677-689.
    >> Share

    December 2019
  59. HERRMANN A, Lahtz C, Song J, Aftabizadeh M, et al
    Integrin alpha6 signaling induces STAT3-TET3-mediated hydroxymethylation of genes critical for maintenance of glioma stem cells.
    Oncogene. 2019 Dec 9. pii: 10.1038/s41388-019-1134.
    >> Share

    November 2019
  60. DONG KS, Chen Y, Yang G, Liao ZB, et al
    TGF-beta1 accelerates the hepatitis B virus X-induced malignant transformation of hepatic progenitor cells by upregulating miR-199a-3p.
    Oncogene. 2019 Nov 18. pii: 10.1038/s41388-019-1107.
    >> Share

  61. CHEN L, De Menna M, Groenewoud A, Thalmann GN, et al
    A NF-kB-Activin A signaling axis enhances prostate cancer metastasis.
    Oncogene. 2019 Nov 18. pii: 10.1038/s41388-019-1103.
    >> Share

  62. SHENG YH, Wong KY, Seim I, Wang R, et al
    MUC13 promotes the development of colitis-associated colorectal tumors via beta-catenin activity.
    Oncogene. 2019;38:7294-7310.
    >> Share

    October 2019
  63. KOUZI F, Zibara K, Bourgeais J, Picou F, et al
    Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells.
    Oncogene. 2019 Oct 24. pii: 10.1038/s41388-019-1069.
    >> Share

  64. YANG W, Li Y, Gao R, Xiu Z, et al
    MHC class I dysfunction of glioma stem cells escapes from CTL-mediated immune response via activation of Wnt/beta-catenin signaling pathway.
    Oncogene. 2019 Oct 7. pii: 10.1038/s41388-019-1045.
    >> Share

  65. VESCHI V, Mangiapane LR, Nicotra A, Di Franco S, et al
    Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant.
    Oncogene. 2019 Oct 7. pii: 10.1038/s41388-019-1047.
    >> Share

  66. TANG K, Yu Y, Zhu L, Xu P, et al
    Hypoxia-reprogrammed tricarboxylic acid cycle promotes the growth of human breast tumorigenic cells.
    Oncogene. 2019;38:6970-6984.
    >> Share

  67. HUANG W, Hu H, Zhang Q, Wu X, et al
    Regulatory networks in mechanotransduction reveal key genes in promoting cancer cell stemness and proliferation.
    Oncogene. 2019;38:6818-6834.
    >> Share

    September 2019
  68. LI D, Tian Y, Hu Y, Qi Y, et al
    Correction: Glioma-associated human endothelial cell-derived extracellular vesicles specifically promote the tumourigenicity of glioma stem cells via CD9.
    Oncogene. 2019 Sep 19. pii: 10.1038/s41388-019-1018.
    >> Share

  69. SUN J, Yan J, Qiao HY, Zhao FY, et al
    Loss of TRIM29 suppresses cancer stem cell-like characteristics of PDACs via accelerating ISG15 degradation.
    Oncogene. 2019 Sep 9. pii: 10.1038/s41388-019-0992.
    >> Share

  70. JI D, Zhang P, Ma W, Fei Y, et al
    Oncogenic heterogeneous nuclear ribonucleoprotein D-like modulates the growth and imatinib response of human chronic myeloid leukemia CD34(+) cells via pre-B-cell leukemia homeobox 1.
    Oncogene. 2019 Sep 5. pii: 10.1038/s41388-019-0998.
    >> Share

    August 2019
  71. SIRKISOON SR, Carpenter RL, Rimkus T, Doheny D, et al
    TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment.
    Oncogene. 2019 Aug 28. pii: 10.1038/s41388-019-0959.
    >> Share

  72. XU BS, Chen HY, Que Y, Xiao W, et al
    ALK(ATI) interacts with c-Myc and promotes cancer stem cell-like properties in sarcoma.
    Oncogene. 2019 Aug 28. pii: 10.1038/s41388-019-0973.
    >> Share

  73. SECKER KA, Keppeler H, Duerr-Stoerzer S, Schmid H, et al
    Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9.
    Oncogene. 2019 Aug 15. pii: 10.1038/s41388-019-0937.
    >> Share

  74. COOK LM, Frieling JS, Nerlakanti N, McGuire JJ, et al
    Betaglycan drives the mesenchymal stromal cell osteogenic program and prostate cancer-induced osteogenesis.
    Oncogene. 2019 Aug 13. pii: 10.1038/s41388-019-0913.
    >> Share

  75. LI D, Tian Y, Hu Y, Qi Y, et al
    Glioma-associated human endothelial cell-derived extracellular vesicles specifically promote the tumourigenicity of glioma stem cells via CD9.
    Oncogene. 2019 Aug 9. pii: 10.1038/s41388-019-0903.
    >> Share

  76. THAKUR VS, Aguila B, Brett-Morris A, Creighton CJ, et al
    Spermidine/spermine N1-acetyltransferase 1 is a gene-specific transcriptional regulator that drives brain tumor aggressiveness.
    Oncogene. 2019 Aug 9. pii: 10.1038/s41388-019-0917.
    >> Share

  77. BEYES S, Andrieux G, Schrempp M, Aicher D, et al
    Genome-wide mapping of DNA-binding sites identifies stemness-related genes as directly repressed targets of SNAIL1 in colorectal cancer cells.
    Oncogene. 2019 Aug 7. pii: 10.1038/s41388-019-0905.
    >> Share

  78. CASLINI C, Hong S, Ban YJ, Chen XS, et al
    HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells.
    Oncogene. 2019 Aug 2. pii: 10.1038/s41388-019-0897.
    >> Share

  79. KIM EH, Jo Y, Sai S, Park MJ, et al
    Tumor-treating fields induce autophagy by blocking the Akt2/miR29b axis in glioblastoma cells.
    Oncogene. 2019 Aug 2. pii: 10.1038/s41388-019-0882.
    >> Share

    July 2019
  80. STETKA J, Vyhlidalova P, Lanikova L, Koralkova P, et al
    Addiction to DUSP1 protects JAK2V617F-driven polycythemia vera progenitors against inflammatory stress and DNA damage, allowing chronic proliferation.
    Oncogene. 2019;38:5627-5642.
    >> Share

    June 2019
  81. WANG Z, Kang L, Zhang H, Huang Y, et al
    AKT drives SOX2 overexpression and cancer cell stemness in esophageal cancer by protecting SOX2 from UBR5-mediated degradation.
    Oncogene. 2019;38:5250-5264.
    >> Share

  82. BERNAT-PEGUERA A, Simon-Extremera P, da Silva-Diz V, Lopez de Munain M, et al
    PDGFR-induced autocrine SDF-1 signaling in cancer cells promotes metastasis in advanced skin carcinoma.
    Oncogene. 2019;38:5021-5037.
    >> Share

  83. TSAI FJ, Lai MT, Cheng J, Chao SC, et al
    Novel K6-K14 keratin fusion enhances cancer stemness and aggressiveness in oral squamous cell carcinoma.
    Oncogene. 2019;38:5113-5126.
    >> Share

  84. AASEN T, Leithe E, Graham SV, Kameritsch P, et al
    Connexins in cancer: bridging the gap to the clinic.
    Oncogene. 2019;38:4429-4451.
    >> Share

  85. HE W, Liang B, Wang C, Li S, et al
    MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer.
    Oncogene. 2019;38:4637-4654.
    >> Share

  86. CHEN C, Bai L, Cao F, Wang S, et al
    Targeting LIN28B reprograms tumor glucose metabolism and acidic microenvironment to suppress cancer stemness and metastasis.
    Oncogene. 2019;38:4527-4539.
    >> Share

    May 2019
  87. TEW BY, Legendre C, Gooden GC, Johnson KN, et al
    Isolation and characterization of patient-derived CNS metastasis-associated stromal cell lines.
    Oncogene. 2019;38:4002-4014.
    >> Share

  88. DAI W, Xu X, Wang D, Wu J, et al
    Cancer therapy with a CRISPR-assisted telomerase-activating gene expression system.
    Oncogene. 2019;38:4110-4124.
    >> Share

    April 2019
  89. HU J, Mirshahidi S, Simental A, Lee SC, et al
    Cancer stem cell self-renewal as a therapeutic target in human oral cancer.
    Oncogene. 2019 Apr 1. pii: 10.1038/s41388-019-0800.
    >> Share

  90. NISHIMURA T, Nakata A, Chen X, Nishi K, et al
    Cancer stem-like properties and gefitinib resistance are dependent on purine synthetic metabolism mediated by the mitochondrial enzyme MTHFD2.
    Oncogene. 2019;38:2464-2481.
    >> Share

    March 2019
  91. WU M, Sheng L, Cheng M, Zhang H, et al
    Low doses of decitabine improve the chemotherapy efficacy against basal-like bladder cancer by targeting cancer stem cells.
    Oncogene. 2019 Mar 27. pii: 10.1038/s41388-019-0799.
    >> Share

  92. WANG L, Zhang Z, Yu X, Huang X, et al
    Unbalanced YAP-SOX9 circuit drives stemness and malignant progression in esophageal squamous cell carcinoma.
    Oncogene. 2019;38:2042-2055.
    >> Share

    February 2019
  93. WANG T, Song P, Zhong T, Wang X, et al
    The inflammatory cytokine IL-6 induces FRA1 deacetylation promoting colorectal cancer stem-like properties.
    Oncogene. 2019 Feb 25. pii: 10.1038/s41388-019-0763.
    >> Share

  94. MUNOZ-GALVAN S, Lucena-Cacace A, Perez M, Otero-Albiol D, et al
    Tumor cell-secreted PLD increases tumor stemness by senescence-mediated communication with microenvironment.
    Oncogene. 2019;38:1309-1323.
    >> Share

  95. ARIMA K, Ohmuraya M, Miyake K, Koiwa M, et al
    Inhibition of 15-PGDH causes Kras-driven tumor expansion through prostaglandin E2-ALDH1 signaling in the pancreas.
    Oncogene. 2019;38:1211-1224.
    >> Share

    January 2019
  96. CASTAGNOLI L, Cancila V, Cordoba-Romero SL, Faraci S, et al
    WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer.
    Oncogene. 2019 Jan 31. pii: 10.1038/s41388-019-0700.
    >> Share

  97. WOOSLEY AN, Dalton AC, Hussey GS, Howley BV, et al
    TGFbeta promotes breast cancer stem cell self-renewal through an ILEI/LIFR signaling axis.
    Oncogene. 2019 Jan 28. pii: 10.1038/s41388-019-0703.
    >> Share

  98. ZHOU H, Yu C, Kong L, Xu X, et al
    B591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells.
    Oncogene. 2019 Jan 11. pii: 10.1038/s41388-018-0674.
    >> Share

  99. DOMENICI G, Aurrekoetxea-Rodriguez I, Simoes BM, Rabano M, et al
    A Sox2-Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells.
    Oncogene. 2019 Jan 8. pii: 10.1038/s41388-018-0656.
    >> Share

  100. GOLD A, Eini L, Nissim-Rafinia M, Viner R, et al
    Spironolactone inhibits the growth of cancer stem cells by impairing DNA damage response.
    Oncogene. 2019 Jan 8. pii: 10.1038/s41388-018-0654.
    >> Share

  101. LAU BW, Huh K, Madero-Marroquin R, De Marchi F, et al
    Hedgehog/GLI1 activation leads to leukemic transformation of myelodysplastic syndrome in vivo and GLI1 inhibition results in antitumor activity.
    Oncogene. 2019;38:687-698.
    >> Share

  102. CHEN-WICHMANN L, Shvartsman M, Preiss C, Hockings C, et al
    Compatibility of RUNX1/ETO fusion protein modules driving CD34+ human progenitor cell expansion.
    Oncogene. 2019;38:261-272.
    >> Share

  103. PATEL Y, Soni M, Awgulewitsch A, Kern MJ, et al
    Overexpression of miR-489 derails mammary hierarchy structure and inhibits HER2/neu-induced tumorigenesis.
    Oncogene. 2019;38:445-453.
    >> Share

  104. BAO Y, Guo Y, Yang Y, Wei X, et al
    PRSS8 suppresses colorectal carcinogenesis and metastasis.
    Oncogene. 2019;38:497-517.
    >> Share

  105. WENG CH, Chen LY, Lin YC, Shih JY, et al
    Epithelial-mesenchymal transition (EMT) beyond EGFR mutations per se is a common mechanism for acquired resistance to EGFR TKI.
    Oncogene. 2019;38:455-468.
    >> Share

    December 2018
  106. LIU S, Yin P, Kujawa SA, Coon JS 5th, et al
    Progesterone receptor integrates the effects of mutated MED12 and altered DNA methylation to stimulate RANKL expression and stem cell proliferation in uterine leiomyoma.
    Oncogene. 2018 Dec 11. pii: 10.1038/s41388-018-0612.
    >> Share

  107. HE Y, Hooker E, Yu EJ, Cunha GR, et al
    Androgen signaling is essential for development of prostate cancer initiated from prostatic basal cells.
    Oncogene. 2018 Dec 3. pii: 10.1038/s41388-018-0583.
    >> Share

  108. OHNO Y, Shingyoku S, Miyake S, Tanaka A, et al
    Differential regulation of the sphere formation and maintenance of cancer-initiating cells of malignant mesothelioma via CD44 and ALK4 signaling pathways.
    Oncogene. 2018;37:6357-6367.
    >> Share

    November 2018
  109. WENG CC, Ding PY, Liu YH, Hawse JR, et al
    Mutant Kras-induced upregulation of CD24 enhances prostate cancer stemness and bone metastasis.
    Oncogene. 2018 Nov 22. pii: 10.1038/s41388-018-0575.
    >> Share

  110. AN J, Du Y, Fan X, Wang Y, et al
    EGFL6 promotes breast cancer by simultaneously enhancing cancer cell metastasis and stimulating tumor angiogenesis.
    Oncogene. 2018 Nov 19. pii: 10.1038/s41388-018-0565.
    >> Share

  111. KUMAR S, Srivastav RK, Wilkes DW, Ross T, et al
    Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer.
    Oncogene. 2018 Nov 15. pii: 10.1038/s41388-018-0562.
    >> Share

  112. HU YB, Yan C, Mu L, Mi YL, et al
    Exosomal Wnt-induced dedifferentiation of colorectal cancer cells contributes to chemotherapy resistance.
    Oncogene. 2018 Nov 2. pii: 10.1038/s41388-018-0557.
    >> Share

  113. OOKI A, Dinalankara W, Marchionni L, Tsay JJ, et al
    Epigenetically regulated PAX6 drives cancer cells toward a stem-like state via GLI-SOX2 signaling axis in lung adenocarcinoma.
    Oncogene. 2018;37:5967-5981.
    >> Share

    October 2018
  114. ZEPECKI JP, Snyder KM, Moreno MM, Fajardo E, et al
    Regulation of human glioma cell migration, tumor growth, and stemness gene expression using a Lck targeted inhibitor.
    Oncogene. 2018 Oct 23. pii: 10.1038/s41388-018-0546.
    >> Share

  115. BAKHSHINYAN D, Venugopal C, Adile AA, Garg N, et al
    BMI1 is a therapeutic target in recurrent medulloblastoma.
    Oncogene. 2018 Oct 22. pii: 10.1038/s41388-018-0549.
    >> Share

  116. SHIMIZU M, Tanaka N
    IL-8-induced O-GlcNAc modification via GLUT3 and GFAT regulates cancer stem cell-like properties in colon and lung cancer cells.
    Oncogene. 2018 Oct 10. pii: 10.1038/s41388-018-0533.
    >> Share

  117. LI B, Xu H, Han H, Song S, et al
    Exosome-mediated transfer of lncRUNX2-AS1 from multiple myeloma cells to MSCs contributes to osteogenesis.
    Oncogene. 2018;37:5508-5519.
    >> Share

    September 2018
  118. PAI VC, Hsu CC, Chan TS, Liao WY, et al
    ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling.
    Oncogene. 2018 Sep 28. pii: 10.1038/s41388-018-0497.
    >> Share

  119. BALAMURUGAN K, Mendoza-Villanueva D, Sharan S, Summers GH, et al
    C/EBPdelta links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes.
    Oncogene. 2018 Sep 27. pii: 10.1038/s41388-018-0516.
    >> Share

  120. CHEN T, Chen J, Zhu Y, Li Y, et al
    CD163, a novel therapeutic target, regulates the proliferation and stemness of glioma cells via casein kinase 2.
    Oncogene. 2018 Sep 26. pii: 10.1038/s41388-018-0515.
    >> Share

  121. NAKANO M, Kikushige Y, Miyawaki K, Kunisaki Y, et al
    Dedifferentiation process driven by TGF-beta signaling enhances stem cell properties in human colorectal cancer.
    Oncogene. 2018 Sep 4. pii: 10.1038/s41388-018-0480.
    >> Share

  122. GOTO H, Shimono Y, Funakoshi Y, Imamura Y, et al
    Adipose-derived stem cells enhance human breast cancer growth and cancer stem cell-like properties through adipsin.
    Oncogene. 2018 Sep 3. pii: 10.1038/s41388-018-0477.
    >> Share

    August 2018
  123. LEE E, Ouzounova M, Piranlioglu R, Ma MT, et al
    The pleiotropic effects of TNFalpha in breast cancer subtypes is regulated by TNFAIP3/A20.
    Oncogene. 2018 Aug 30. pii: 10.1038/s41388-018-0472.
    >> Share

  124. BONETTI P, Climent M, Panebianco F, Tordonato C, et al
    Dual role for miR-34a in the control of early progenitor proliferation and commitment in the mammary gland and in breast cancer.
    Oncogene. 2018 Aug 9. pii: 10.1038/s41388-018-0445.
    >> Share

  125. TOSHIYAMA R, Konno M, Eguchi H, Takemoto H, et al
    Poly(ethylene glycol)-poly(lysine) block copolymer-ubenimex conjugate targets aminopeptidase N and exerts an antitumor effect in hepatocellular carcinoma stem cells.
    Oncogene. 2018 Aug 8. pii: 10.1038/s41388-018-0406.
    >> Share

  126. LIU Z, Zhang W, Phillips JB, Arora R, et al
    Immunoregulatory protein B7-H3 regulates cancer stem cell enrichment and drug resistance through MVP-mediated MEK activation.
    Oncogene. 2018 Aug 6. pii: 10.1038/s41388-018-0407.
    >> Share

  127. MAURIZI G, Verma N, Gadi A, Mansukhani A, et al
    Sox2 is required for tumor development and cancer cell proliferation in osteosarcoma.
    Oncogene. 2018;37:4626-4632.
    >> Share

  128. HANDLER J, Cullis J, Avanzi A, Vucic EA, et al
    Pre-neoplastic pancreas cells enter a partially mesenchymal state following transient TGF-beta exposure.
    Oncogene. 2018;37:4334-4342.
    >> Share

    July 2018
  129. LU CH, Yeh DW, Lai CY, Liu YL, et al
    USP17 mediates macrophage-promoted inflammation and stemness in lung cancer cells by regulating TRAF2/TRAF3 complex formation.
    Oncogene. 2018 Jul 23. pii: 10.1038/s41388-018-0411.
    >> Share

  130. SHI L, Tang X, Qian M, Liu Z, et al
    A SIRT1-centered circuitry regulates breast cancer stemness and metastasis.
    Oncogene. 2018 Jul 23. pii: 10.1038/s41388-018-0370.
    >> Share

  131. LUO L, Tang H, Ling L, Li N, et al
    LINC01638 lncRNA activates MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation in triple-negative breast cancer.
    Oncogene. 2018 Jul 12. pii: 10.1038/s41388-018-0396.
    >> Share

  132. JI C, Yang L, Yi W, Xiang D, et al
    Capillary morphogenesis gene 2 maintains gastric cancer stem-like cell phenotype by activating a Wnt/beta-catenin pathway.
    Oncogene. 2018;37:3953-3966.
    >> Share

  133. ZIMMERLI D, Cecconi V, Valenta T, Hausmann G, et al
    WNT ligands control initiation and progression of human papillomavirus-driven squamous cell carcinoma.
    Oncogene. 2018;37:3753-3762.
    >> Share

    May 2018
  134. LIAO CP, Lin TP, Li PC, Geary LA, et al
    Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate.
    Oncogene. 2018 May 29. pii: 10.1038/s41388-018-0325.
    >> Share

  135. GABBASOV R, Xiao F, Howe CG, Bickel LE, et al
    NEDD9 promotes oncogenic signaling, a stem/mesenchymal gene signature, and aggressive ovarian cancer growth in mice.
    Oncogene. 2018 May 18. pii: 10.1038/s41388-018-0296.
    >> Share

  136. GRUN D, Adhikary G, Eckert RL
    NRP-1 interacts with GIPC1 and alpha6/beta4-integrins to increase YAP1/Np63alpha-dependent epidermal cancer stem cell survival.
    Oncogene. 2018 May 14. pii: 10.1038/s41388-018-0290.
    >> Share

  137. BAKER A, Wyatt D, Bocchetta M, Li J, et al
    Notch-1-PTEN-ERK1/2 signaling axis promotes HER2+ breast cancer cell proliferation and stem cell survival.
    Oncogene. 2018 May 10. pii: 10.1038/s41388-018-0251.
    >> Share

  138. LI N, Zhang Y, Sidlauskas K, Ellis M, et al
    Inhibition of GPR158 by microRNA-449a suppresses neural lineage of glioma stem/progenitor cells and correlates with higher glioma grades.
    Oncogene. 2018 May 3. pii: 10.1038/s41388-018-0277.
    >> Share

  139. CHEN A, Sceneay J, Godde N, Kinwel T, et al
    Intermittent hypoxia induces a metastatic phenotype in breast cancer.
    Oncogene. 2018 May 1. pii: 10.1038/s41388-018-0259.
    >> Share

  140. TAKAHASHI K, Ehata S, Koinuma D, Morishita Y, et al
    Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells.
    Oncogene. 2018;37:2757-2772.
    >> Share

    April 2018
  141. TOOSI BM, El Zawily A, Truitt L, Shannon M, et al
    EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours.
    Oncogene. 2018 Apr 27. pii: 10.1038/s41388-018-0228.
    >> Share

    March 2018
  142. MONTERISI S, Riso PL, Russo K, Bertalot G, et al
    HOXB7 overexpression in lung cancer is a hallmark of acquired stem-like phenotype.
    Oncogene. 2018 Mar 26. pii: 10.1038/s41388-018-0229.
    >> Share

    February 2018
  143. CAJA L, Tzavlaki K, Dadras MS, Tan EJ, et al
    Snail regulates BMP and TGFbeta pathways to control the differentiation status of glioma-initiating cells.
    Oncogene. 2018 Feb 16. pii: 10.1038/s41388-018-0136.
    >> Share

  144. MANCINI R, Noto A, Pisanu ME, De Vitis C, et al
    Metabolic features of cancer stem cells: the emerging role of lipid metabolism.
    Oncogene. 2018 Feb 15. pii: 10.1038/s41388-018-0141.
    >> Share

  145. IDOUX-GILLET Y, Nassour M, Lakis E, Bonini F, et al
    Slug/Pcad pathway controls epithelial cell dynamics in mammary gland and breast carcinoma.
    Oncogene. 2018;37:578-588.
    >> Share

    January 2018
  146. AKHTER MZ, Sharawat SK, Kumar V, Kochat V, et al
    Aggressive serous epithelial ovarian cancer is potentially propagated by EpCAM(+)CD45(+) phenotype.
    Oncogene. 2018 Jan 30. pii: 10.1038/s41388-017-0106.
    >> Share

  147. O'BRIEN KP, Khan S, Gilligan KE, Zafar H, et al
    Employing mesenchymal stem cells to support tumor-targeted delivery of extracellular vesicle (EV)-encapsulated microRNA-379.
    Oncogene. 2018 Jan 25. pii: 10.1038/s41388-017-0116.
    >> Share

  148. SOLOMON H, Dinowitz N, Pateras IS, Cooks T, et al
    Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers.
    Oncogene. 2018 Jan 18. pii: 10.1038/s41388-017-0060.
    >> Share

    December 2017
  149. PENG F, Wang JH, Fan WJ, Meng YT, et al
    Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia.
    Oncogene. 2017 Dec 18. pii: onc2017407. doi: 10.1038/onc.2017.
    >> Share

    November 2017
  150. ALMIRON BONNIN DA, Havrda MC, Lee MC, Liu H, et al
    Secretion-mediated STAT3 activation promotes self-renewal of glioma stem-like cells during hypoxia.
    Oncogene. 2017 Nov 20. doi: 10.1038/onc.2017.
    >> Share

  151. PENG F, Wang JH, Fan WJ, Meng YT, et al
    Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia.
    Oncogene. 2017 Nov 6. doi: 10.1038/onc.2017.
    >> Share

    October 2017
  152. DEBEBE A, Medina V, Chen CY, Mahajan IM, et al
    Wnt/beta-catenin activation and macrophage induction during liver cancer development following steatosis.
    Oncogene. 2017;36:6020-6029.
    >> Share

  153. OTANI Y, Ichikawa T, Kurozumi K, Inoue S, et al
    Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion.
    Oncogene. 2017 Oct 23. doi: 10.1038/onc.2017.
    >> Share

  154. SIZEMORE GM, Balakrishnan S, Hammer AM, Thies KA, et al
    Stromal PTEN inhibits the expansion of mammary epithelial stem cells through Jagged-1.
    Oncogene. 2017 Oct 16. doi: 10.1038/onc.2017.
    >> Share

  155. VISVANATHAN A, Patil V, Arora A, Hegde AS, et al
    Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance.
    Oncogene. 2017 Oct 9. doi: 10.1038/onc.2017.
    >> Share

  156. WANG CH, Wang PJ, Hsieh YC, Lo S, et al
    Resistin facilitates breast cancer progression via TLR4-mediated induction of mesenchymal phenotypes and stemness properties.
    Oncogene. 2017 Oct 9. doi: 10.1038/onc.2017.
    >> Share

    September 2017
  157. YOUN H, Lee HK, Sohn HR, Park UH, et al
    RaRF confers RA resistance by sequestering RAR to the nucleolus and regulating MCL1 in leukemia cells.
    Oncogene. 2017 Sep 25. doi: 10.1038/onc.2017.
    >> Share

  158. WANG F, Wang AY, Chesnelong C, Yang Y, et al
    ING5 activity in self-renewal of glioblastoma stem cells via calcium and follicle stimulating hormone pathways.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    >> Share

  159. DEBRUYNE DN, Turchi L, Burel-Vandenbos F, Fareh M, et al
    DOCK4 promotes loss of proliferation in glioblastoma progenitor cells through nuclear beta-catenin accumulation and subsequent miR-302-367 cluster expression.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    >> Share

  160. KIM M, Jang K, Miller P, Picon-Ruiz M, et al
    VEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug.
    Oncogene. 2017;36:5199-5211.
    >> Share

    August 2017
  161. LI XX, Zhang HS, Xu YM, Zhang RJ, et al
    Knockdown of IRE1alpha inhibits colonic tumorigenesis through decreasing beta-catenin and IRE1alpha targeting suppresses colon cancer cells.
    Oncogene. 2017 Aug 21. doi: 10.1038/onc.2017.
    >> Share

  162. LI J, Hu SB, Wang LY, Zhang X, et al
    Autophagy-dependent generation of Axin2+ cancer stem-like cells promotes hepatocarcinogenesis in liver cirrhosis.
    Oncogene. 2017 Aug 7. doi: 10.1038/onc.2017.
    >> Share

    July 2017
  163. FETTIG LM, McGinn O, Finlay-Schultz J, LaBarbera DV, et al
    Cross talk between progesterone receptors and retinoic acid receptors in regulation of cytokeratin 5-positive breast cancer cells.
    Oncogene. 2017 Jul 10. doi: 10.1038/onc.2017.
    >> Share

    June 2017
  164. PISTORE C, Giannoni E, Colangelo T, Rizzo F, et al
    DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells.
    Oncogene. 2017 Jun 5. doi: 10.1038/onc.2017.
    >> Share

  165. SENGUPTA S, Nagalingam A, Muniraj N, Bonner MY, et al
    Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3.
    Oncogene. 2017 Jun 5. doi: 10.1038/onc.2017.
    >> Share

  166. PEREZ-ALEA M, McGrail K, Sanchez-Redondo S, Ferrer B, et al
    ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment.
    Oncogene. 2017 Jun 5. doi: 10.1038/onc.2017.
    >> Share

    May 2017
  167. RAJA E, Komuro A, Tanabe R, Sakai S, et al
    Bone morphogenetic protein signaling mediated by ALK-2 and DLX2 regulates apoptosis in glioma-initiating cells.
    Oncogene. 2017 May 1. doi: 10.1038/onc.2017.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016